4th Mar 2026 07:00
4 March 2026
Animalcare Group plc
("Animalcare", the "Company", or together with its subsidiaries, the "Group")
Capital Markets Event: In Good Health
Delivering the next stage of growth, to achieve 2030 revenue and EBITDA ambitions
Animalcare Group Plc (AIM: ANCR), the international animal health business, is today hosting a Capital Markets Event to provide greater insight into the three pillars of its growth strategy and outline opportunities to accelerate its growth in the near to medium-term.
Over the past five years, Animalcare has undergone a period of transformation, resulting in a rationalised portfolio of higher quality offerings, expanded geographic reach and strengthened balance sheet. More recently, this progress has been accelerated by the earnings accretive acquisition of Randlab, the Australia-based Equine business, and the development of a growing R&D pipeline with transformative growth potential.
As part of today's presentations, the Group will introduce new medium-term financial ambitions, including reaching around £150m of revenue with a pathway to 25% EBITDA margin by 2030. Leveraging Animalcare's established and strong commercial platform, these ambitions reflect opportunities to accelerate organic growth in the near to medium-term through investing in activities such as expanding the dental franchise, improving manufacturing efficiency and pursuing selective and accretive M&A.
No updates on current trading will be provided during the meeting.
Details of the presentation
The Capital Markets Event will take place today from 2pm at Stifel's offices in London for pre-registered attendees. Hosted by Animalcare's CEO, Jennifer Winter, and CFO, Chris Brewster, the event will feature presentations from the senior management team, followed by an opportunity to ask questions. Should you wish to attend, please contact [email protected] for further details.
A copy of the presentation will be made available on the Company's website following the event, with a full replay of the event available in the coming days.
This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014, as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"). Upon the publication of this announcement, this inside information is now considered to be in the public domain. The person responsible for arranging for the release of this announcement on behalf of the Company is Chris Brewster, CFO.
For more information, please contact:
Animalcare Group Plc Jenny Winter, Chief Executive OfficerChris Brewster, Chief Financial OfficerMedia/investor relations | +44 (0)1904 487 687
|
Stifel (Nominated Advisor & Joint Broker) Ben Maddison Francis North Jason Grossman | Tel: +44 (0)20 7710 7600
|
Panmure Liberum (Joint Broker) Corporate Finance Emma Earl, Freddy Crossley Corporate Banking Rupert Dearden | +44 (0)20 7886 2500 |
Alma Strategic Communications Caroline Forde Kinvara Verdon Rose Docherty | +44 (0)20 3405 0205 |
About Animalcare
Animalcare Group plc is a UK AIM-listed international veterinary sales and marketing organisation. Animalcare operates in seven European countries as well as Australia and New Zealand and exports to approximately 40 countries in Europe and worldwide. The Group is focused on bringing new and innovative products to market through its own development pipeline, partnerships and via acquisition.
For more information about Animalcare, please visit www.animalcaregroup.com
Related Shares:
Animalcare Grp